The following data is part of a premarket notification filed by Carrington Laboratories, Inc. with the FDA for Carraklenz And Ultraklenz.
Device ID | K022670 |
510k Number | K022670 |
Device Name: | CARRAKLENZ AND ULTRAKLENZ |
Classification | Dressing, Wound, Drug |
Applicant | CARRINGTON LABORATORIES, INC. 49 PLAIN ST. North Attleboro, MA 02760 |
Contact | Mary Mc-namara-culinane |
Correspondent | Mary Mc-namara-culinane CARRINGTON LABORATORIES, INC. 49 PLAIN ST. North Attleboro, MA 02760 |
Product Code | FRO |
CFR Regulation Number | 510(k) Premarket Notification [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2002-08-12 |
Decision Date | 2002-10-17 |
Summary: | summary |